Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 USD | -2.86% | -8.72% | +96.53% |
14/05 | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
09/05 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.53% | 34.11M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.93% | 21.97B | |
-5.71% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- SNSE Stock
- News Sensei Biotherapeutics, Inc.
- Sensei Biotherapeutics, National Cancer Institute to Collaborate on SNS-101 Development; Shares Gain Premarket